​The food industry is one of the UK's most resilient and essential sectors, but it is also one of the most dynamic.

Manufacturers are constantly required to adapt, whether that's responding to day-to-day operational challenges on the factory floor or navigating major global events that reshape supply chains, consumer behaviour and market demand.

Over the past few years alone, businesses have faced disruption from Brexit, Covid-19, the war in Ukraine and ongoing tensions across the Middle East. These events have highlighted the importance of not only having a Plan A, but also Plans B, C and sometimes even D. In today's market, being able to adapt is no longer an advantage, it's a necessity.

One thing that remains certain is that the food industry will continue to evolve and recover from challenges. However, the speed at which businesses adapt will determine how quickly they can bounce back.

More recently, food manufacturers are dealing with the rise of GLP-1 medications.

More than a year on from their global launch, consumer data is beginning to paint a clearer picture of how these products are impacting purchasing habits and what manufacturers can do to stay ahead of the curve.

Many early forecasts focused on declining calorie consumption and overall consumption. Whilst there is evidence that GLP-1 users reduce portion sizes and eat less frequently, we’re seeing food spending habits are evolving rather than disappearing altogether.

Consumers taking GLP-1 medications are increasingly prioritising:

Higher protein foods

Nutrient-dense products

Functional ingredients

Health-focused snacks

Foods that deliver satiety and nutritional value

For categories such as confectionery, sugary snacks and highly indulgent products, there has naturally been a decline in demand and consumption. But for those sought-after categories, there are new opportunities to succeed.

Why Food Manufacturers Shouldn't Panic

Consumer use is widely varied, so whilst they have been highly sought after, the majority of the UK market aren’t using the “Fat Jabs”.

This means the industry is unlikely to see an overnight decline in demand. Instead, manufacturers should prepare for an ongoing change in consumer preferences.

Historically, we have seen that successful food businesses are those that adapt to changing customer needs rather than simply reacting to short-term market trends. The rise of plant-based foods, clean-label products and high-protein ranges all demonstrate how quickly consumer preferences can reshape markets.

​

The Manufacturers Best Positioned for Success

As consumer preferences evolve, certain manufacturers are already well placed to benefit businesses within the categories of: high-protein products, dairy & cultured foods, functional nutrition, healthy snacking and sports & performance nutrition. They are all likely to see an overall benefit to the subscriptions.

However, launching products labelled as "GLP-1 friendly" won’t be enough, as the trend of the industry is that consumers will prioritise taste, convenience and value alongside health benefits.

Three Ways Manufacturers Can Stay Ahead

1. Invest in Consumer Insight

Understanding how purchasing habits are changing within your specific category will be critical. It’s no different from reviewing the data across the factories to look at marginal gains that can be made. Businesses that are in the know will be able to adapt to consumer changes faster than competitors. 

2. Prioritise Product Innovation

NPD has always been crucial for manufacturers, and launching products in line with what people want will ensure you remain competitive. Small adaptations can make a huge impact, and businesses should be looking at increased protein content, improved nutritional density, enhanced fibre levels, low sugar content and developing portion-controlled formats.

Whilst none of these trends are new to the industry, they are far more crucial now.

3.Focus on Premium Value

Whilst consumption levels are dropping, it seems that GLP-1 users are still spending the same amount, if not more, as they choose products they perceive as healthier, more functional or higher quality.

The rise of GLP-1 medications is unlikely to be the business-closing threat that was predicted for the food industry. However, it does represent a significant shift in consumer behaviour that manufacturers cannot afford to ignore.

 The businesses that thrive over the coming years will be those that view GLP-1 adoption as a catalyst for innovation rather than a reason for concern.

 Consumers may be eating differently, but they will still demand products that are convenient, enjoyable, nutritious and relevant to their lifestyles.

 For food manufacturers, the opportunity is clear: understand the changing consumer, innovate with purpose and stay close to the trends shaping tomorrow's market.